Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: European Union
  • Asset Class: Equity
  • Geographic Focus: European Union

UBAM - Europe Equity

+ Add to Watchlist

UBAMEAE:LX

436.21 EUR 3.68 0.85%

As of 01:59:30 ET on 03/04/2015.

Snapshot for UBAM - Europe Equity (UBAMEAE)

Year To Date: +13.17% 3-Month: +11.97% 3-Year: - 52-Week Range: 339.04 - 438.55
1-Month: +4.67% 1-Year: +20.28% 5-Year: - Beta vs MXEU: 1.01

Mutual Fund Chart for UBAMEAE

No chart data available.
  • UBAMEAE:LX 436.21
  • 1M
  • 1Y
Interactive UBAMEAE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UBAMEAE

UBAM - Europe Equity is a compartment of a Luxembourg SICAV. The Fund's objective is capital appreciation. The Fund invests primarily in equities and similar securities issued by European companies.

Inception Date: 03-27-2012 Telephone: 41-58-819-2800 Tel
Managers: ROBERT JONES / SCOTT MEECH
Web Site: www.ubp.com

Fundamentals for UBAMEAE

NAV (on 2015-03-04) 436.21
Assets (M) (on 2015-03-04) 709.84
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for UBAMEAE

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for UBAMEAE

Front Load -
Back Load -
Current Mgmt Fee 1.50
Redemption Fee -
12b1 Fee -
Expense Ratio 2.11

Top Fund Holdings for UBAMEAE

Filing Date: 11/28/2014
Name Position Value % of Total
Novartis AG 280,063 21,800,683 4.720%
Nestle SA 319,325 19,287,374 4.176%
Royal Dutch Shell PLC 664,431 17,836,650 3.862%
HSBC Holdings PLC 2,178,611 17,433,267 3.775%
Bayer AG 137,615 16,644,534 3.604%
AstraZeneca PLC 243,047 14,594,117 3.160%
Roche Holding AG 59,876 14,426,270 3.123%
ING Groep NV 1,039,920 12,250,258 2.652%
Anheuser-Busch InBev NV 124,907 11,798,715 2.555%
AXA SA 580,246 11,265,476 2.439%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil